Who Supplies Nivolumab? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Nivolumab exports, with 23+ registered manufacturers shipping to buyers across 13+ countries — yet a handful of companies dominate the shipments. DR.REDDY'S LABORATORIES LTD holds the largest share at 46.0% (export value: $1.1M). Close behind, CORSANTRUM TECHNOLOGY (25.3%, $577.3K). VAMA LIFECARE PRIVATE LIMITED (9.5%, $217.8K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Nivolumab? Top Manufacturers & Their Buyers
Flow of Nivolumab from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Nivolumab Supplier Network — Key Market Intelligence
The Nivolumab export market from India is led by DR.REDDY'S LABORATORIES LTD, which alone commands a 46.0% share, shipping $1.1M worth of product across 15 shipments. The second-largest exporter, CORSANTRUM TECHNOLOGY, contributes $577.3K (25.3%) to the overall market. Combined, the top two suppliers alone account for 71.3% of all Nivolumab exports, indicating a relatively concentrated supply base.
Across all 23 tracked manufacturers, the total Nivolumab export value stands at $2.3M from 144 shipments. The market average shipment value is $15.9K. The single largest buyer relationship in terms of trade value is ALMAC PHARMACEUTICAL SERVICES PTE LIMITED, receiving $1.1M worth of product.
The combined buyer network spans 13 named purchasing companies, including ALMAC PHARMACEUTICAL SERVICES PTE LIMITED, COREX LLC, LABCORP EARLY DEVELO, BIOPHARMASPEC INC, CHARLES RIVER LABORA and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the first-largest Nivolumab exporter from India, with a market share of 46.0% and a total export value of $1.1M across 15 shipments. Their average shipment value of $70.1K is above the market average of $15.9K, suggesting premium or bulk contract pricing.
DR.REDDY'S LABORATORIES LTD serves 1 named buyer in our database. ALMAC PHARMACEUTICAL SERVICES PTE LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• ALMAC PHARMACEUTICAL SERVICES PTE LIMITED — $1.1M across 15 shipments (100.0% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $70.1K is 342% above the market average of $15.9K, consistent with large-order contracts or value-added formulations.
2CORSANTRUM TECHNOLOGY
CORSANTRUM TECHNOLOGY is the second-largest Nivolumab exporter from India, with a market share of 25.3% and a total export value of $577.3K across 22 shipments. Their average shipment value of $26.2K is above the market average of $15.9K, suggesting premium or bulk contract pricing.
CORSANTRUM TECHNOLOGY serves 5 named buyers in our database. COREX LLC is the dominant customer, accounting for 96.2% of this supplier's tracked business. Top customers include:
• COREX LLC — $555.6K across 21 shipments (96.2% of this supplier's total exports)
• LABCORP EARLY DEVELO — $20.9K across 1 shipments (3.6% of this supplier's total exports)
• BIOPHARMASPEC INC — $525 across 0 shipments (0.1% of this supplier's total exports)
• CHARLES RIVER LABORA — $250 across 0 shipments (0.0% of this supplier's total exports)
• CERGENTIS B.V. — $30 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: CORSANTRUM TECHNOLOGY's per-shipment value of $26.2K is 66% above the market average of $15.9K, consistent with large-order contracts or value-added formulations.
3VAMA LIFECARE PRIVATE LIMITED
VAMA LIFECARE PRIVATE LIMITED is the third-largest Nivolumab exporter from India, with a market share of 9.5% and a total export value of $217.8K across 7 shipments. Their average shipment value of $31.1K is above the market average of $15.9K, suggesting premium or bulk contract pricing.
VAMA LIFECARE PRIVATE LIMITED serves 1 named buyer in our database. COREX LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• COREX LLC — $217.8K across 7 shipments (100.0% of this supplier's total exports)
Key Insight: VAMA LIFECARE PRIVATE LIMITED's per-shipment value of $31.1K is 96% above the market average of $15.9K, consistent with large-order contracts or value-added formulations.
4MODERN DRUG HOUSE
MODERN DRUG HOUSE is the fourth-largest Nivolumab exporter from India, with a market share of 3.3% and a total export value of $74.3K across 15 shipments. Their average shipment value of $5.0K is below the market average of $15.9K, reflecting a high-volume, competitive pricing strategy.
MODERN DRUG HOUSE serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• JAIR CARLOS DE ARAUJO — $30.5K across 6 shipments (41.0% of this supplier's total exports)
• FRANCISCO EUDES DA SILVA — $11.8K across 2 shipments (15.9% of this supplier's total exports)
• ELIZETE DE OLIVEIRA DA SILVA — $11.8K across 2 shipments (15.9% of this supplier's total exports)
• RINEA IVETE ROOS BOER — $11.2K across 2 shipments (15.1% of this supplier's total exports)
• MARIA DE FATIMA ROCH — $8.9K across 2 shipments (12.0% of this supplier's total exports)
Key Insight: MODERN DRUG HOUSE operates with high shipment frequency (15 shipments) at a per-shipment value of $5.0K, indicating a broad distribution network with many smaller, regular orders.
5SPECIALITY MEDICINES LIMITED
SPECIALITY MEDICINES LIMITED is the fifth-largest Nivolumab exporter from India, with a market share of 3.2% and a total export value of $72.9K across 10 shipments. Their average shipment value of $7.3K is below the market average of $15.9K, reflecting a high-volume, competitive pricing strategy.
SPECIALITY MEDICINES LIMITED serves 1 named buyer in our database. AS PER INVOICE is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• AS PER INVOICE — $72.9K across 10 shipments (100.0% of this supplier's total exports)
Key Insight: SPECIALITY MEDICINES LIMITED operates with high shipment frequency (10 shipments) at a per-shipment value of $7.3K, indicating a broad distribution network with many smaller, regular orders.
6RBN MEDITECH PRIVATE LIMITED
RBN MEDITECH PRIVATE LIMITED is the fifth-largest Nivolumab exporter from India, with a market share of 1.2% and a total export value of $27.6K across 12 shipments. Their average shipment value of $2.3K is below the market average of $15.9K, reflecting a high-volume, competitive pricing strategy.
RBN MEDITECH PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF- — $10.9K across 5 shipments (39.5% of this supplier's total exports)
• TO THE ORDER OF- — $8.9K across 4 shipments (32.2% of this supplier's total exports)
• TO THE ORDER OF- — $4.4K across 2 shipments (16.1% of this supplier's total exports)
• TO THE ORDER OF- — $2.2K across 1 shipments (8.1% of this supplier's total exports)
• DR TSUTOMU TAKEDA — $1.1K across 0 shipments (4.1% of this supplier's total exports)
Key Insight: RBN MEDITECH PRIVATE LIMITED operates with high shipment frequency (12 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Nivolumab Flows
Once Nivolumab leaves the manufacturing plants of companies like DR.REDDY'S LABORATORIES LTD and CORSANTRUM TECHNOLOGY, it travels to 5 destination markets with a combined import value of $2.3M. Singapore absorbs the largest share at 46.0% ($1.1M), followed by Russia (33.9%) and Brazil (12.3%).
In Singapore — the top destination — named importers include ALMAC PHARMACEUTICAL SERVICES PTE LIMITED. In Russia, key buyers are COREX LLC.
This geographic spread reflects Nivolumab's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Nivolumab Go? Top Importing Countries & Their Buyers
Trade flow of Nivolumab exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Singapore
Singapore ranks as the first-largest destination for Nivolumab imports from India, with a total trade value of $1.1M across 2 shipments — representing a 46.0% share of all Nivolumab exports. The average shipment value of $525.6K is above the global average of $15.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Nivolumab importers in Singapore: ALMAC PHARMACEUTICAL SERVICES PTE LIMITED is the largest buyer, accounting for 100.0% ($1.1M) of this market's total imports.
• ALMAC PHARMACEUTICAL SERVICES PTE LIMITED — $1.1M (100.0% of Singapore's total)
Key Insight: Singapore's per-shipment average of $525.6K (3216% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Singapore is a key market for Nivolumab imports from India.
2Russia
Russia ranks as the second-largest destination for Nivolumab imports from India, with a total trade value of $773.4K across 8 shipments — representing a 33.9% share of all Nivolumab exports. The average shipment value of $96.7K is above the global average of $15.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Nivolumab importers in Russia: COREX LLC is the largest buyer, accounting for 100.0% ($773.4K) of this market's total imports.
• COREX LLC — $773.4K (100.0% of Russia's total)
Key Insight: Russia's per-shipment average of $96.7K (510% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Nivolumab imports from India.
3Brazil
Brazil ranks as the third-largest destination for Nivolumab imports from India, with a total trade value of $280.5K across 23 shipments — representing a 12.3% share of all Nivolumab exports. The average shipment value of $12.2K is below the global average of $15.9K, consistent with generic/API volume purchasing. This market is served by 7 tracked buyers.
Named Nivolumab importers in Brazil: AS PER INVOICE is the largest buyer, accounting for 26.0% ($72.9K) of this market's total imports.
• AS PER INVOICE — $72.9K (26.0% of Brazil's total)
• JAIR CARLOS DE ARAUJO — $30.5K (10.9% of Brazil's total)
• FRANCISCO EUDES DA SILVA — $11.8K (4.2% of Brazil's total)
Key Insight: Brazil receives frequent, smaller shipments of Nivolumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Brazil is a key market for Nivolumab imports from India.
4Seychelles
Seychelles ranks as the fourth-largest destination for Nivolumab imports from India, with a total trade value of $56.6K across 4 shipments — representing a 2.5% share of all Nivolumab exports. The average shipment value of $14.2K is below the global average of $15.9K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Nivolumab importers in Seychelles: HEALTH CARE AGENCY is the largest buyer, accounting for 38.4% ($21.7K) of this market's total imports.
• HEALTH CARE AGENCY — $21.7K (38.4% of Seychelles's total)
• INVOICE RAISED TO SEYCHELLES — $11.8K (20.8% of Seychelles's total)
Key Insight: Seychelles receives frequent, smaller shipments of Nivolumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Seychelles is a key market for Nivolumab imports from India.
5Maldives
Maldives ranks as the fifth-largest destination for Nivolumab imports from India, with a total trade value of $54.8K across 11 shipments — representing a 2.4% share of all Nivolumab exports. The average shipment value of $5.0K is below the global average of $15.9K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Nivolumab importers in Maldives: STATE TRADING ORGANIZATION PLC is the largest buyer, accounting for 58.9% ($32.3K) of this market's total imports.
• STATE TRADING ORGANIZATION PLC — $32.3K (58.9% of Maldives's total)
• INDIRA GANDHI MEMORIAL HOSPITAL — $12.0K (22.0% of Maldives's total)
Key Insight: Maldives receives frequent, smaller shipments of Nivolumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Maldives is a key market for Nivolumab imports from India.
People Also Ask — Nivolumab Supplier & Trade Network
Who are the top suppliers of Nivolumab from India?+
Which companies buy Nivolumab from Indian manufacturers?+
Where does Nivolumab exported from India go?+
What is the market share of the top Nivolumab supplier from India?+
What is the average shipment value for Nivolumab exports from India?+
Is Nivolumab manufactured in India and exported globally?+
Which country imports the most Nivolumab from India?+
Who are the buyers of Nivolumab in Russia?+
How concentrated is the Nivolumab supplier market in India?+
How do I find verified buyers for Nivolumab in specific countries?+
Nivolumab Trade Network — Key Takeaways
- 1DR.REDDY'S LABORATORIES LTD is India's dominant Nivolumab exporter with a 46.0% market share and $1.1M in total exports — making it the single most important sourcing entity in this market.
- 2The top 23 suppliers collectively account for 88.5% of all tracked Nivolumab exports, with a combined trade value of $2.3M.
- 3Singapore is the largest destination market, absorbing 46.0% of India's Nivolumab exports ($1.1M). Russia (33.9%) and Brazil (12.3%) follow.
- 4With 144 total shipments averaging $15.9K each, the Nivolumab export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ALMAC PHARMACEUTICAL SERVICES PTE LIMITED, COREX LLC, LABCORP EARLY DEVELO, COREX LLC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 13 countries
Network value: $2.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nivolumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Nivolumab.
- 2.Flow Mapping: 23 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 144 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 13 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
144 Verified Shipments
23 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists